List of works - Mariona Parera

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions

scientific article published in August 2002

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

article

Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

scientific article published on July 2005

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients

scientific article

Epistasis among deleterious mutations in the HIV-1 protease

scientific article

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness

scientific article published on 29 August 2012

Genetic and catalytic efficiency structure of an HCV protease quasispecies

scientific article published in April 2007

Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease

scientific article published on December 2004

Gut Microbiota Linked to Sexual Preference and HIV Infection.

scientific article

HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions

scientific article

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

scientific article published on 28 June 2012

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

scientific article published on January 2014

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

scientific article

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

scientific article

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy

scientific article published on 5 April 2004

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

article

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

scientific article published on 14 February 2018

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

article

List of works by Mariona Parera

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients

Epistasis among deleterious mutations in the HIV-1 protease

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness

Genetic and catalytic efficiency structure of an HCV protease quasispecies

Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease

Gut Microbiota Linked to Sexual Preference and HIV Infection.

HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication